159 related articles for article (PubMed ID: 22254159)
21. Chemical modification of glycyrrhizic acid as a route to new bioactive compounds for medicine.
Baltina LA
Curr Med Chem; 2003 Jan; 10(2):155-71. PubMed ID: 12570715
[TBL] [Abstract][Full Text] [Related]
22. Neuroprotective and Anti-inflammatory Effects of a Dodecamer Peptide Harboring Ninjurin 1 Cell Adhesion Motif in the Postischemic Brain.
Lee HK; Kim ID; Lee H; Luo L; Kim SW; Lee JK
Mol Neurobiol; 2018 Jul; 55(7):6094-6111. PubMed ID: 29177697
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic effects of stronger neo-minophagen C at different doses on chronic hepatitis and liver cirrhosis.
Iino S; Tango T; Matsushima T; Toda G; Miyake K; Hino K; Kumada H; Yasuda K; Kuroki T; Hirayama C; Suzuki H
Hepatol Res; 2001 Jan; 19(1):31-40. PubMed ID: 11137478
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of intravenous glycyrrhizin in the early stage of acute onset autoimmune hepatitis.
Yasui S; Fujiwara K; Tawada A; Fukuda Y; Nakano M; Yokosuka O
Dig Dis Sci; 2011 Dec; 56(12):3638-47. PubMed ID: 21681505
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic effects of glycyrrhizin in mice infected with LP-BM5 murine retrovirus and mechanisms involved in the prevention of disease progression.
Watanbe H; Miyaji C; Makino M; Abo T
Biotherapy; 1996; 9(4):209-20. PubMed ID: 9012540
[TBL] [Abstract][Full Text] [Related]
26. A preliminary open trial on interferon stimulator (SNMC) derived from Glycyrrhiza glabra in the treatment of subacute hepatic failure.
Acharya SK; Dasarathy S; Tandon A; Joshi YK; Tandon BN
Indian J Med Res; 1993 Apr; 98():69-74. PubMed ID: 8344734
[TBL] [Abstract][Full Text] [Related]
27. A drug over the millennia: pharmacognosy, chemistry, and pharmacology of licorice.
Shibata S
Yakugaku Zasshi; 2000 Oct; 120(10):849-62. PubMed ID: 11082698
[TBL] [Abstract][Full Text] [Related]
28. [The present status in prophylaxis and treatment of HIV infected patients with hemophilia in Japan].
Mori K; Sakai H; Suzuki S; Akutsu Y; Ishikawa M; Aihara M; Yokoyama M; Sato Y; Okaniwa S; Endo Y
Rinsho Byori; 1989 Nov; 37(11):1200-8. PubMed ID: 2689699
[TBL] [Abstract][Full Text] [Related]
29. A decrease in AFP level related to administration of interferon in patients with chronic hepatitis C and a high level of AFP.
Murashima S; Tanaka M; Haramaki M; Yutani S; Nakashima Y; Harada K; Ide T; Kumashiro R; Sata M
Dig Dis Sci; 2006 Apr; 51(4):808-12. PubMed ID: 16615008
[TBL] [Abstract][Full Text] [Related]
30. Effect of glycyrrhizin in children with liver dysfunction associated with cytomegalovirus infection.
Numazaki K; Umetsu M; Chiba S
Tohoku J Exp Med; 1994 Feb; 172(2):147-53. PubMed ID: 8073426
[TBL] [Abstract][Full Text] [Related]
31. [Molecular mechanisms of the protection of SNMC in HepG2 cell apoptosis].
Wang Y; Ma YJ; Yang BS; Bi MR; Chen LY
Zhonghua Gan Zang Bing Za Zhi; 2005 Feb; 13(2):132-5. PubMed ID: 15727703
[TBL] [Abstract][Full Text] [Related]
32. Anti-inflammatory and anti-excitoxic effects of diethyl oxopropanamide, an ethyl pyruvate bioisoster, exert robust neuroprotective effects in the postischemic brain.
Lee HK; Kim ID; Kim SW; Lee H; Park JY; Yoon SH; Lee JK
Sci Rep; 2017 Feb; 7():42891. PubMed ID: 28220827
[TBL] [Abstract][Full Text] [Related]
33. Anti-Zn
Luo L; Kim SW; Lee HK; Kim ID; Lee H; Lee JK
Cell Mol Neurobiol; 2018 Apr; 38(3):615-626. PubMed ID: 28608001
[TBL] [Abstract][Full Text] [Related]
34. Glycyrrhizin protects brain against ischemia-reperfusion injury in mice through HMGB1-TLR4-IL-17A signaling pathway.
Zhang J; Wu Y; Weng Z; Zhou T; Feng T; Lin Y
Brain Res; 2014 Sep; 1582():176-86. PubMed ID: 25111887
[TBL] [Abstract][Full Text] [Related]
35. Neuroprotective effect of triflusal and its main metabolite, 2-hydroxy-4-trifluoromethylbenzoic acid (HTB), in the postischemic brain.
Kim SW; Choi KJ; Park JY; Yoon SH; Lee JK
Neurosci Lett; 2017 Mar; 643():59-64. PubMed ID: 28189746
[TBL] [Abstract][Full Text] [Related]
36. Effects of glycyrrhizin (SNMC: stronger Neo-Minophagen C) in hemophilia patients with HIV infection.
Mori K; Sakai H; Suzuki S; Sugai K; Akutsu Y; Ishikawa M; Seino Y; Ishida N; Uchida T; Kariyone S
Tohoku J Exp Med; 1989 May; 158(1):25-35. PubMed ID: 2781539
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of the cerebral ischemic injury by ethyl pyruvate with a wide therapeutic window.
Yu YM; Kim JB; Lee KW; Kim SY; Han PL; Lee JK
Stroke; 2005 Oct; 36(10):2238-43. PubMed ID: 16141417
[TBL] [Abstract][Full Text] [Related]
38. Glycyrrhizin ameliorates oxidative stress and inflammation in hippocampus and olfactory bulb in lithium/pilocarpine-induced status epilepticus in rats.
González-Reyes S; Santillán-Cigales JJ; Jiménez-Osorio AS; Pedraza-Chaverri J; Guevara-Guzmán R
Epilepsy Res; 2016 Oct; 126():126-33. PubMed ID: 27490898
[TBL] [Abstract][Full Text] [Related]
39. [Efficacy and safety of Stronger Neo-Minophagen C for treatment of chronic hepatitis B: a meta-analysis of randomized controlled trials].
Chen J; Wang J; Qin T; Huang Y; Li J
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Jul; 34(8):1224-9. PubMed ID: 25176104
[TBL] [Abstract][Full Text] [Related]
40. A Previously Unknown Drug-Drug Interaction Is Suspected in Delayed Elimination of Plasma Methotrexate in High-Dose Methotrexate Therapy.
Ishizaki J; Nakano C; Kitagawa K; Suga Y; Sai Y
Ann Pharmacother; 2020 Jan; 54(1):29-35. PubMed ID: 31416331
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
